SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-391030
Filing Date
2014-10-31
Accepted
2014-10-31 09:01:21
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d787905d10q.htm 10-Q 603735
2 EX-31.1 d787905dex311.htm EX-31.1 7785
3 EX-31.2 d787905dex312.htm EX-31.2 7782
4 EX-32.1 d787905dex321.htm EX-32.1 5329
  Complete submission text file 0001193125-14-391030.txt   3698346

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT glyc-20140930.xml EX-101.INS 435373
6 XBRL TAXONOMY EXTENSION SCHEMA glyc-20140930.xsd EX-101.SCH 34181
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glyc-20140930_cal.xml EX-101.CAL 39791
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glyc-20140930_def.xml EX-101.DEF 144467
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE glyc-20140930_lab.xml EX-101.LAB 291552
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glyc-20140930_pre.xml EX-101.PRE 209502
Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 141184953
SIC: 2834 Pharmaceutical Preparations